发明名称 TRANSDERMAL THERAPEUTIC SYSTEM HAVING CONTROLLED ACTIVE SUBSTANCE FLOW COMPRISING BASIC-REACTING OXIDE
摘要 PROBLEM TO BE SOLVED: To provide a transdermal therapeutic system which can avoid problems of stability in spite of using preferable permeability of an active ingredient base, and at that time, can regulate a permeation rate thereof on a given level without needing to provide a control membrane into the transdermal therapeutic system.SOLUTION: A transdermal therapeutic system contains an occlusive back layer impervious to an active substance, a monolayer or multilayer matrix, and a peelable protective film, where the matrix or at least one of the matrix layers comprises a pharmaceutical active substance or a plurality of pharmaceutical active substances in a salt form which can be pharmaceutically used, and an alkaline-reacting oxide which can be pharmaceutically used.
申请公布号 JP2015212286(A) 申请公布日期 2015.11.26
申请号 JP20150134023 申请日期 2015.07.03
申请人 LTS LOHMANN THERAPIE-SYSTEME AG 发明人 RENE EIFLER;REGINE KAUFMANN;PATRICK MOHR
分类号 A61K47/02;A61K9/70;A61K31/13;A61K45/00;A61K47/32;A61K47/34;A61P25/16;A61P25/28 主分类号 A61K47/02
代理机构 代理人
主权项
地址